FOX BIZ NEWS: Better Big Pharma Stock: AbbVie vs. AstraZeneca


Better Big Pharma Stock: AbbVie vs. AstraZeneca



These A-list drugmakers must both contend with expiring patents, new drug uncertainties, and hungry competitors. But they're in different stages of their cyclical journeys.

Comments

Post a Comment

Popular posts from this blog